Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

MEDTRONIC ($MDT) Releases Q3 2026 Earnings

None

MEDTRONIC ($MDT) posted quarterly earnings results for Q3 2026 on Tuesday, February 17th. The company reported earnings of $1.36 per share, beating estimates of $1.35 by $0.01. The company also reported revenue of $9,017,000,000, beating estimates of $8,994,097,379 by $22,902,621.

You can see Quiver Quantitative's $MDT stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

MEDTRONIC Insider Trading Activity

MDT Insider Trades

MEDTRONIC insiders have traded $MDT stock on the open market 11 times in the past 6 months. Of those trades, 2 have been purchases and 9 have been sales.

Here’s a breakdown of recent trading of $MDT stock by insiders over the last 6 months:

  • GREGORY L SMITH (EVP Global Ops & Supply Chain) has made 0 purchases and 7 sales selling 30,000 shares for an estimated $3,058,451.
  • HARRY SKIP KIIL (EVP & President Cardiovascular) has made 0 purchases and 2 sales selling 8,605 shares for an estimated $788,047.
  • WILLIAM R JELLISON has made 2 purchases buying 5,000 shares for an estimated $462,750 and 0 sales.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

MEDTRONIC Hedge Fund Activity

We have seen 1,038 institutional investors add shares of MEDTRONIC stock to their portfolio, and 1,084 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

MEDTRONIC Congressional Stock Trading

Members of Congress have traded $MDT stock 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $MDT stock by members of Congress over the last 6 months:

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

MEDTRONIC Analyst Ratings

Wall Street analysts have issued reports on $MDT in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Barclays issued a "Overweight" rating on 01/08/2026
  • William Blair issued a "Outperform" rating on 01/06/2026
  • RBC Capital issued a "Outperform" rating on 11/19/2025
  • Morgan Stanley issued a "Overweight" rating on 11/19/2025
  • Wells Fargo issued a "Overweight" rating on 11/19/2025
  • Citigroup issued a "Buy" rating on 10/07/2025
  • Argus Research issued a "Buy" rating on 08/26/2025

To track analyst ratings and price targets for MEDTRONIC, check out Quiver Quantitative's $MDT forecast page.

MEDTRONIC Price Targets

Multiple analysts have issued price targets for $MDT recently. We have seen 14 analysts offer price targets for $MDT in the last 6 months, with a median target of $112.0.

Here are some recent targets:

  • Matt Miksic from Barclays set a target price of $116.0 on 02/13/2026
  • Mike Matson from Needham set a target price of $121.0 on 02/09/2026
  • Lee Hambright from Bernstein set a target price of $112.0 on 01/09/2026
  • Richard Newitter from Truist Securities set a target price of $107.0 on 12/18/2025
  • Larry Biegelsen from Wells Fargo set a target price of $114.0 on 11/19/2025
  • David Rescott from Baird set a target price of $109.0 on 11/19/2025
  • Shagun Singh from RBC Capital set a target price of $118.0 on 11/19/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles